Erythromelalgia: Identification of a corticosteroid-responsive subset.

Pagani-Estévez, Gabriel L; Sandroni, Paola; Davis, Mark D; Watson, James C

Pagani-Estévez, Gabriel L; Sandroni, Paola; Davis, Mark D; Watson, James C.

Affiliation

Pagani-Estévez GL; Department of Neurology, Mayo Clinic, Rochester, Minnesota.
Sandroni P; Department of Neurology, Mayo Clinic, Rochester, Minnesota.
Davis MD; Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
Watson JC; Department of Neurology, Mayo Clinic, Rochester, Minnesota; Department of Anesthesiology, Pain Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: watson.james@mayo.edu.

J Am Acad Dermatol ; 76(3): 506-511.e1, 2017 Mar.

Article in En | MEDLINE | ID: mdl-28413058

Subject(s)

Anti-Inflammatory Agents/therapeutic use; Erythromelalgia/drug therapy; Prednisone/therapeutic use; Adolescent; Adult; Aged; Erythromelalgia/etiology; Female; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult

Key words

corticosteroids; erythromelalgia; immunotherapy; pain; treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prednisone / Erythromelalgia / Anti-Inflammatory Agents Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Acad Dermatol Year: 2017 Type: Article

Fulltext

XML

PubMed Links

Search on Google